Search results for "Standard"

showing 10 items of 3299 documents

Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view.

2014

Randomized Controlled Trials (RCTs) are the "gold standard" for evaluating treatment outcomes providing information on treatments "efficacy". They are designed to test a therapeutic hypothesis under optimal setting in the absence of confounding factors. For this reason they have high internal validity. The strict and controlled conditions in which they are conducted, leads to low generalizability because they are performed in conditions very different from real life usual care. Conversely, real life studies inform on the "effectiveness" of a treatment, that is, the measure of the extent to which an intervention does what is intended to do in routine circumstances. At variance to RCTs, real …

Pulmonary and Respiratory MedicineChronic Obstructivemedicine.medical_specialtyAsthma; COPD; Randomized controlled trials; Real life studies; Asthma; Confounding Factors (Epidemiology); Humans; Pulmonary Disease Chronic Obstructive; Randomized Controlled Trials as Topic; Research Design; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)Alternative medicineSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionPulmonary DiseasePulmonary Disease Chronic ObstructiveRandomized controlled triallawIntervention (counseling)medicineCOPDHumansPharmacology (medical)Generalizability theoryMedical physicsInternal validityReal life studiesRandomized Controlled Trials as Topicbusiness.industryBiochemistry (medical)Gold standardConfounding Factors EpidemiologicVariance (accounting)Confounding Factors (Epidemiology)AsthmaReal life studieRandomized controlled trials; Real life studies; Asthma; COPDRandomized controlled trialResearch DesignRandomized controlled trialsPhysical therapybusinessStrengths and weaknesses
researchProduct

Towards the determination of isoprene in human breath using substrate-integrated hollow waveguide mid-infrared sensors

2014

Selected volatile organic compounds (VOCs) in breath may be considered biomarkers if they are indicative of distinct diseases or disease states. Given the inherent molecular selectivity of vibrational spectroscopy, infrared sensing technologies appear ideally suitable for the determination of endogenous VOCs in breath. The aim of this study was to determine that mid-infrared (MIR; 3-20 µm) gas phase sensing is capable of determining isoprene in exhaled breath as an exemplary medically relevant VOC by hyphenating novel substrate-integrated hollow waveguides (iHWG) with a likewise miniaturized preconcentration system. A compact preconcentrator column for sampling isoprene from exhaled breath …

Pulmonary and Respiratory MedicineDetection limitTime FactorsInfrared RaysTemperatureAnalytical chemistryInfrared spectroscopySignal Processing Computer-AssistedBiosensing TechniquesSubstrate (electronics)Reference StandardsHollow waveguidechemistry.chemical_compoundHemiterpenesBreath TestsBreath gas analysischemistryPentanesTemporal resolutionCalibrationButadienesCalibrationHumansIsopreneJournal of Breath Research
researchProduct

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

2021

Abstract Introduction In contrast to other driver mutations, no targeted therapies have yet been approved in ERBB2-mutated NSCLC (HER2mu NSCLC). Nevertheless, several compounds have revealed promising early efficacy data, which need to be evaluated in the context of current standard approaches. Although data on the efficacy of immune checkpoint inhibitors (ICIs) in second or subsequent lines of treatment remain limited and conflicting, there are virtually no data on patient outcome under ICI/platinum-doublet combinations in the first-line setting. Methods We retrospectively evaluated outcomes of patients with HER2mu NSCLC treated with ICI alone or in combination with chemotherapy within the…

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyLung NeoplasmsStandard of careReceptor ErbB-2Immune checkpoint inhibitorsmedicine.medical_treatmentMedizinPatient characteristicsContext (language use)Internal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansGenomic medicineLung cancerImmune Checkpoint InhibitorsRetrospective StudiesChemotherapybusiness.industryImmunotherapymedicine.diseaseOncologyMutationbusiness
researchProduct

Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.

2012

The objective of this in-vitro study was to determine whether admixtures of the inhalation solutions Pulmozyme(®) (Dornase alfa) and either Bramitob(®) or Tobi(®) (both containing Tobramycin) are physicochemically compatible and to analyze the aerodynamic parameters of these admixtures. After mixing, test solutions were stored at room temperature and under ambient light conditions over a period of 24 h. Tobramycin concentrations were determined by using a fluorescence immunoassay. Stability of dornase alfa was determined by size-exclusion high performance liquid chromatography, ultraviolet spectroscopy, sodium dodecyl sulfate polyacrylamide gel electrophoresis and tentacle strong cation-exc…

Pulmonary and Respiratory MedicineTime FactorsDrug StorageHigh-performance liquid chromatographyDrug Incompatibilitychemistry.chemical_compoundDrug StabilityAdministration InhalationmedicineTobramycinGeometric standard deviationDeoxyribonuclease IPharmacology (medical)Sodium dodecyl sulfateParticle SizeAerosolsChromatographyInhalationNebulizers and VaporizersBiochemistry (medical)Osmolar ConcentrationDornase alfaHydrogen-Ion ConcentrationRecombinant ProteinsAnti-Bacterial AgentsDrug CombinationsPharmaceutical SolutionschemistryCompatibility (mechanics)TobramycinFeasibility StudiesParticle fractionmedicine.drugPulmonary pharmacologytherapeutics
researchProduct

Évaluation de la pratique chirurgicale dans le traitement du cancer bronchique en France à partir de la base nationale du PMSI

2019

Background - In recent years, improving the quality of care has been a concern for health professionals in France, through the certification of institutions, accreditation and continuous professional development. Evaluation of these different measures has rarely been carried out. The objective of the study was to evaluate the quality of surgical management of lung cancer in different regions using hospital mortality as an indicator. Method - From the national database of the Program of Medical Information Systems (PMSI), data on all patients who had undergone surgery for lung cancer were extracted as well as the characteristics of the centers. The main outcome criterion was hospital mortali…

Pulmonary and Respiratory MedicineVolume d’activitésmedicine.medical_specialtyGrippe[SDV.CAN]Life Sciences [q-bio]/CancerEpidémie saisonnière03 medical and health sciences0302 clinical medicineHospital volumeBase de données nationales médico-administrative[SDV.CAN] Life Sciences [q-bio]/Cancermedicine030212 general & internal medicineChirurgieGynecologybusiness.industryRisk standardized rate of mortalityPMSI3. Good healthHospital volumeTaux standardisé de mortalité030228 respiratory systemCancer du poumonNational databaseFranceLung cancerbusinessHôpitalSurgery Medico-administrative database
researchProduct

Prognostic Value of Troponins in Patients With or Without Coronary Heart Disease: Is it Dependent on Structure and Biology?

2020

Convincing evidence has emerged that cardiac troponins (cTns) T and I are the biochemical gold standard for diagnosing cardiac injury, and may also be used as efficient screening and risk stratification tools, especially when measured with the new high-sensitivity (hs-) immunoassays. In this narrative review, we aim to explore and critically discuss the results of recent epidemiological studies that have attempted to characterise the prognostic value of cTns in patients with or without cardiovascular disease, and then interpret this information according to cTn biology. Overall, all recent studies agree that higher blood levels of cTns reflect the larger risk of cardiovascular events and/or…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCoronary heart disease; Mortality; Prediction; Risk stratification; TroponinPopulationCoronary DiseaseDisease030204 cardiovascular system & hematologyBioinformatics03 medical and health sciences0302 clinical medicineTroponin complexTroponin TEpidemiologyTroponin ImedicineHumans030212 general & internal medicineMortalityeducationRisk stratificationeducation.field_of_studybiologybusiness.industryC-reactive proteinTroponin IGold standard (test)TroponinTroponinCoronary heart diseaseC-Reactive Proteinbiology.proteinCardiology and Cardiovascular MedicinebusinessPredictionBiomarkers
researchProduct

Maximal regularity via reverse Hölder inequalities for elliptic systems of n-Laplace type involving measures

2008

In this note, we consider the regularity of solutions of the nonlinear elliptic systems of n-Laplacian type involving measures, and prove that the gradients of the solutions are in the weak Lebesgue space Ln,∞. We also obtain the a priori global and local estimates for the Ln,∞-norm of the gradients of the solutions without using BMO-estimates. The proofs are based on a new lemma on the higher integrability of functions.

Pure mathematicsNonlinear systemLemma (mathematics)Laplace transformElliptic systemsGeneral MathematicsMathematical analysisMathematicsofComputing_NUMERICALANALYSISStandard probability spaceA priori and a posterioriType (model theory)Mathematical proofMathematics
researchProduct

Riesz and Wolff potentials and elliptic equations in variable exponent weak Lebesgue spaces

2015

Submitted by Alexandre Almeida (jaralmeida@ua.pt) on 2015-11-12T11:41:07Z No. of bitstreams: 1 RieszWolff_RIA.pdf: 159825 bytes, checksum: d99abdf3c874f47195619a31ff5c12c7 (MD5) Approved for entry into archive by Bella Nolasco(bellanolasco@ua.pt) on 2015-11-17T12:18:41Z (GMT) No. of bitstreams: 1 RieszWolff_RIA.pdf: 159825 bytes, checksum: d99abdf3c874f47195619a31ff5c12c7 (MD5) Made available in DSpace on 2015-11-17T12:18:41Z (GMT). No. of bitstreams: 1 RieszWolff_RIA.pdf: 159825 bytes, checksum: d99abdf3c874f47195619a31ff5c12c7 (MD5) Previous issue date: 2015-04

Pure mathematicsWolff potentialScale (ratio)Weak Lebesgue spaceVariable exponentMathematics::Classical Analysis and ODEsLebesgue's number lemmaNon-standard growth conditionIntegrability of solutionssymbols.namesakeMathematics - Analysis of PDEsReal interpolationFOS: MathematicsLp spaceMathematicsLaplace's equationMathematics::Functional AnalysisVariable exponentIntegrability estimatesRiesz potentialApplied MathematicsMathematical analysisFunctional Analysis (math.FA)Mathematics - Functional AnalysissymbolsRiesz potential47H99 (Primary) 46B70 46E30 35J60 31C45 (Secondary)Analysis of PDEs (math.AP)
researchProduct

On density and π-weight of Lp(βN,R, μ)

2012

In Integration Theory, it is important to establish the separability or not of Lebesgue spaces of the type Lp, with 1 ≤ p < +∞. In general, the usual proof of this type of results for certain Lebesgue spaces, is conducted through methods of Real Analysis. In this work, we use some concepts and methods of pure General Topology in proving the non-separability of a particular Lebesgue space. Further, we provide some estimates for density and π-weight of such a space.

Pure mathematicsselective separability Lebesgue spaceselective separabilitylcsh:MathematicsseparabilityMathematical analysis[MATH.MATH-FA] Mathematics [math]/Functional Analysis [math.FA]lcsh:QA299.6-433Separabilitylcsh:AnalysisSpace (mathematics)lcsh:QA1-939[MATH.MATH-GN] Mathematics [math]/General Topology [math.GN]Lebesgue spaceStandard probability spaceGeometry and TopologySelective separabilityMathematics
researchProduct

Quasilinear elliptic equations with singular quadratic growth terms

2011

In this paper, we deal with positive solutions for singular quasilinear problems whose model is [Formula: see text] where Ω is a bounded open set of ℝN, g ≥ 0 is a function in some Lebesgue space, and γ &gt; 0. We prove both existence and nonexistence of solutions depending on the value of γ and on the size of g.

Quadratic growthnonlinear elliptic equations; natural growth condition; vertical asymptote; measure dataApplied MathematicsGeneral MathematicsMathematical analysisOpen setmeasure dataFunction (mathematics)nonlinear elliptic equationsBounded functionvertical asymptoteStandard probability spacenatural growth conditionAsymptoteValue (mathematics)Mathematics
researchProduct